Early Infectious Complications after High-Dose Therapy and Autologous Blood Stem Cell Transplantation

Publisher： Karger

E-ISSN： 2296-5262|22|6|491-496

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.6, 2000-01, pp. : 491-496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High‐dose therapy and autologous stem cell transplantation for children with HIV‐associated non‐Hodgkin lymphoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 984-987

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

By  

Acta Haematologica, Vol. 110, Iss. 4, 2003-12 ,pp. : 173-178

Karger

Access to resources Recommend Favorite

High-Dose Cyclophosphamide Therapy Associated with Diffuse Alveolar Hemorrhage after Allogeneic Hematopoietic Stem Cell Transplantation

By  

Respiration, Vol. 86, Iss. 6, 2012-12 ,pp. : 453-461

Karger

Access to resources Recommend Favorite

Early viral complications following CD34‐selected autologous peripheral blood stem cell transplantation for non‐Hodgkin's lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 1998-02 ,pp. : 348-350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?

By Cheng Yee Chung   Ueno Naoto T  

Women's Health, Vol. 6, Iss. 4, 2010-07 ,pp. : 481-485

Future Medicine

Access to resources Recommend Favorite